Urinary Catheter News
-
Infection Prevention through Clean Water: How Healthcare Facilities Can Mitigate Healthcare-Associated Infections from Water
Healthcare-associated infections or HAIs are infections people get while they are receiving health care for another condition. These infections can happen in all types of healthcare settings and are a significant cause of patient illness and death. According to the Centers for Disease Control and Prevention (CDC), 1 in 31 patients experience a healthcare-associated infection on any given day, ...
-
CD Bioparticles Introduces Hydrophilic Coatings for Medical Applications
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, recently introduced hydrophilic coatings and related services for medical applications, which can be used within interventional medical devices of the cardiovascular, circulatory, nervous, urinary, and vascular system. Functional medical coatings are a class of interface materials applied to the ...
-
New Technology Leads to Decreased Hemolysis Rates
Laboratories in an increasing number of U. S. hospitals and healthcare systems are seeing significantly lower hemolysis rates in the blood specimens their staff are collecting with new technology designed for drawing blood with a single-use, sterile device that advances into the vein through a peripheral IV (PIV). The technology, PIVO (Velano Vascular, San Francisco, California), is ...
-
Validation through Patient Journey Mapping
Wearing a urinary catheter represents a huge challenge for patients, with Quality of Life implications right from the first moment. Catheter-related Quality of Life studies are scarce, so we decided to organize a specific workshop with patients from different clinical backgrounds in order to openly talk about their experience. We also managed to introduce the T-Control concept to the ...
-
Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization
SAN FRANCISCO, Dec. 17, 2019 (GLOBE NEWSWIRE) — Vascular access technology pioneer Velano Vascular today announced that it has closed the second tranche of a $25 million growth financing that will fuel commercialization and the launch of additional novel inpatient medical device solutions. This new investment builds on an initial tranche closed in the first half of 2019 and brings ...
-
Frost & Sullivan awards N8 Medical New Product Innovation Award for its Platform Medical Device Technology to Prevent Hospital-Acquired Infections
N8 Medical, LLC (N8 Medical) today announced it has been selected as the winner of a North American New Product Innovation Award by Frost & Sullivan, a leader in global research and consulting solutions. N8 Medical is developing disruptive medical devices that prevent hospital-acquired infections and their expensive and potentially fatal consequences. N8 Medical earned the award for its ...
-
World MRSA Awareness Month and Protecting the Residents of Puerto Rico from Microbial Exposure Risks
The month of October has been designated as World MRSA Awareness Month. The recognition is meant to draw attention to the seriousness of this superbug infection and spread information on ways to prevent its proliferation. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that can be found on many people’s skin or even in their nose. For those who develop a ...
-
Cardiva Medical Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology Procedures
VASCADE MVP is the first vessel closure technology designed for electrophysiology procedures – and proven by electrophysiology physicians in a multi-center, randomized, controlled clinical trial. Potential procedures include cardiac ablation and left atrial appendage closure among others. Greater than 400,000 patients per year in the United States may benefit – with procedures ...
-
Cardiva Medical Announces Positive Results of the AMBULATE Pivotal Study Evaluating the VASCADE MVP System Compared to Manual Compression for Multi-Vessel Closure Following Electrophysiology Procedures
The AMBULATE pivotal study met its primary efficacy endpoint. The median time to patients getting on their feet following arrhythmia ablation procedures was reduced by 3.9 hours. AMBULATE demonstrated that patients in the VASCADE MVP arm had significantly improved patient satisfaction and a significant reduction in the post-procedure use of opioid pain medications. Late-breaking results were ...
-
Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat
N8 Medical, LLC today announced a peer-reviewed publication in The Journal of Antimicrobial Chemotherapy with U.S. Centers for Disease Control and Prevention (CDC) co-authors of promising efficacy data regarding the activity of ceragenin CSA-131 against 100 strains of Candida auris (C. auris) collected from around the world. C. auris is a highly virulent and lethal pathogen of key clinical ...
-
dBMEDx™ , Inc. Wins the 2016 Prime Health Challenge
dBMEDx was selected as the winner of the 2016 Prime Health Challenge. The company received a $75,000 cash award and was selected by two hospital groups to host a pilot clinical study of the new BBS Revolution™ bladder scanner, which was first launched by the company in 2015. The BBS RevolutionTM is a next generation bladder scanner that offers nurses, for the first time, a fully automated ...
By dBMEDx
-
dBMEDx™ , Inc. Announces CE Mark for BBS Revolution™ Bladder Scanner
dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has received the CE Mark for the BBS Revolution™, a next generation bladder scanner which offers, for the first time, fully automated bladder detection and unparalleled ease of use, speed and accuracy for the non-invasive measurement of bladder volume. This product is currently FDA cleared and is being ...
By dBMEDx
-
Silver Bullet Therapeutics Announces Allowance of Two New Patents and Commercial Availability of the OrthoFuzIon Antimicrobial Bone Screw System
Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the U.S. Patent and Trademark Office allowed two new patents that include, COATINGS FOR THE CONTROLLABLE RELEASE OF ANTIMICROBIAL METAL IONS and BONE IMPLANT AND SYSTEMS THAT CONTROLLABLY RELEASES SILVER. The Company also announced that they will make the OrthoFuzIon Antimicrobial Bone Screw System ...
-
Silver Bullet Therapeutics Announces Issuance of U.S. Patent No. 8,999,367 for Bioabsorbable Substrates That Controllably Release Metal Ions
Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the U.S. Patent and Trademark Office issued Patent No. 8,999,367 as a continuation of patent No. 8,927,004 that significantly enhances the claims for the release of antimicrobial metal ions to prevent infection. Paul Chirico, President and CEO of Silver Bullet Therapeutics stated, “We take a lot ...
-
dBMEDx Announces FDA Clearance of the BBS Revolution™ Bladder Scanner
dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its novel bladder scanner, the BBS RevolutionTM , a device offering unparalleled ease of use, speed and accuracy for the non-invasive measurement of bladder volume. Bladder scanning is a critical component of a ...
By dBMEDx
-
dBMEDx™ , Inc. Closes Round of Funding, Selected for Venture Showcase
dBMEDx™ , Inc., a privately-held, wireless medical device company, announces the closing of a capital raise of $1.3 million through the sale of common stock, the company’s third successful capital raise. In addition, the company announces that it has been selected to present at the Colorado BioScience Association’s 2014 BioWest Venture Showcase on September 10. The proceeds ...
By dBMEDx
-
dBMEDx Offers Big Results with Small Equipment
The tricorder was a multifunctional device used for sensor scanning, recording and analyzing data to help diagnose disease and collect bodily information about a patient. That fictional object of the future is — in current day — becoming a reality, thanks to dBMEDx, a company offering a hand-held ultrasound scanner called the BBS Revolution that can be used for medical assessments. ...
By dBMEDx
-
Global market for disposable medical supplies to reach nearly $200 billion in 2016
A combination of upgrading and enforcement of infection prevention standards coupled with an expanding volume of hospital, surgical and outpatient procedures will promote overall gains in the global market for disposable medical supplies. Disposable medical gloves, a segment of this market, will continue to flourish despite increasing raw material costs and severe cost-cutting measures in the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you